| |
| |
|
| Insider
Information: |
Smith Robin L |
| Relationship: |
Director |
| City: |
Melville |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,019,592 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$440,195 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,019,592 |
|
|
| Total
Value |
$440,195 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 104.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Lisata Therapeutics Ord Shs |
LSTA |
Executive Chair of the... |
2015-06-02 |
347,285 |
2006-06-02 |
0 |
Premium* |
|
|
Viridian Therapeutics Ors Shs |
VRDN |
Director |
2017-02-03 |
1,900 |
2015-07-17 |
0 |
Premium* |
|
|
Rockwell Medical Technologies Inc |
RMTI |
Director |
2019-06-06 |
31,366 |
2017-03-21 |
0 |
Premium* |
|
|
Sorrento Therapeutics Inc |
SRNE |
Director |
2021-09-03 |
235,000 |
|
0 |
Premium* |
|
|
Servicesource International, Inc. |
SREV |
Director |
2020-05-20 |
167,975 |
2020-03-05 |
0 |
Premium* |
|
|
Gx Acquisition Corp. |
GXGXU |
Director |
2023-06-14 |
236,066 |
2022-07-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GXGXU |
Gx Acquisition Corp. |
Director |
– • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
199,921 |
236,066 |
0 |
- |
|
| GXGXU |
Gx Acquisition Corp. |
Director |
– • – |
2022-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
36,145 |
36,145 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Director |
– • – |
2021-09-03 |
4 |
OE |
$3.95 |
$785,250 |
D/D |
175,000 |
235,000 |
0 |
- |
|
| SREV |
Servicesource Internation... |
Director |
– • – |
2020-05-20 |
4 |
B |
$1.70 |
$85,000 |
D/D |
50,000 |
167,975 |
2.39 |
% |
|
| SREV |
Servicesource Internation... |
Director |
– • – |
2020-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
117,975 |
0 |
- |
|
| SREV |
Servicesource Internation... |
Director |
– • – |
2020-03-05 |
4 |
A |
$0.00 |
$0 |
D/D |
17,975 |
17,975 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Director |
– • – |
2020-03-05 |
4 |
B |
$2.27 |
$90,896 |
D/D |
40,000 |
60,000 |
2.39 |
% |
|
| SRNE |
Sorrento Therapeutics Inc |
Director |
– • – |
2019-12-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
20,000 |
|
- |
|
| RMTI |
Rockwell Medical Technolo... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
21,566 |
31,366 |
0 |
- |
|
| RMTI |
Rockwell Medical Technolo... |
Director |
– • – |
2017-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
9,800 |
9,800 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2017-02-03 |
4 |
OE |
$7.65 |
$9,180 |
D/D |
1,200 |
1,900 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2015-08-06 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
10,500 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2015-08-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,125 |
5,500 |
0 |
- |
|
| VRDN |
Viridian Therapeutics Ors... |
Director |
– • – |
2015-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,375 |
1,375 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Executive Chair of the Board |
• • – |
2015-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
347,285 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Exec. Chairman of the Board |
• • – |
2015-01-16 |
4 |
D |
$3.48 |
$70,007 |
D/D |
(20,117) |
309,293 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Exec. Chairman of the Board |
• • – |
2015-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
39,276 |
329,410 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman and CEO |
• • – |
2014-12-31 |
4 |
A |
$3.20 |
$11,139 |
D/D |
3,476 |
290,134 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
See Remarks |
• • – |
2014-06-30 |
4 |
A |
$5.54 |
$11,139 |
D/D |
2,010 |
286,658 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman of the Board and CEO |
• • – |
2014-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
94,000 |
284,648 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman of the Board and CEO |
• • – |
2013-12-31 |
4 |
A |
$4.85 |
$10,141 |
D/D |
2,093 |
190,648 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman of the Board and CEO |
• • – |
2013-03-06 |
4 |
A |
$0.53 |
$53,000 |
D/D |
100,000 |
1,849,553 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman of the Board and CEO |
• • – |
2012-09-18 |
4 |
B |
$0.69 |
$24,840 |
D/D |
36,000 |
1,749,533 |
2.81 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman of the Board and CEO |
• • – |
2012-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
1,713,533 |
0 |
- |
|
| LSTA |
Lisata Therapeutics Ord S... |
Chairman of the Board and CEO |
• • – |
2012-07-05 |
4 |
A |
$0.52 |
$78,000 |
D/D |
150,000 |
1,659,533 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
